PRESS RELEASE published on 06/18/2026 at 18:30, 4 months 16 days ago Inside Information / Other news releases Theraclion announces changes in its Board of Directors with Mr. Yann Duchesne stepping down and new appointments made. New Interim Chairman appointed. Details on the company's MedTech advancements Board Of Directors MedTech Theraclion SONOVEIN HIFU
PRESS RELEASE published on 06/18/2026 at 18:30, 4 months 16 days ago Informations privilégiées / Autres communiqués THERACLION annonce l'évolution de son conseil d'administration avec le départ de M. Yann Duchesne et la nomination d'un nouveau CA et d'un président par intérim Conseil D'administration Theraclion SONOVEIN Yann Duchesne Claude Lenoir
BRIEF published on 12/09/2025 at 18:35, 10 months 26 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 10 months 26 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 10 months 26 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 10 months 26 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 10 months 26 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 10 months 26 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 1 year ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
BRIEF published on 10/29/2025 at 18:35, 1 year ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
Published on 11/04/2026 at 23:10, 5 hours 46 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 56 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 6 hours 41 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 51 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:45, 11 minutes ago Une princesse de Bourbon rejoint PinkPrincess, marque française de soins de luxe d’inspiration royale, à l’occasion de son lancement mondial
Published on 11/05/2026 at 04:45, 11 minutes ago Bourbon Princess Joins French Royal-Level Skincare Brand PinkPrincess for Global Debut
Published on 11/05/2026 at 04:15, 41 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:15, 41 minutes ago D’Aba à Paris : HEARTH LIGHT ouvre un nouveau chapitre des échanges internationaux autour du patrimoine culturel immatériel
Published on 11/05/2026 at 04:00, 56 minutes ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/04/2026 at 18:00, 10 hours 56 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 56 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 11 hours 12 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
